The burden of HIV disease in the United States is monitored by using a comprehensive surveillance system . Data from this system are used at the federal, state, and local levels to plan, implement, and evaluate public health policies and programs . Implementation of HIV reporting has differed by area, and for the first time in early 2013, estimated data on diagnosed HIV infection were available from all 50 states, the District of Columbia, and six U.S. dependent areas. The newly available data for the entire U.S. as well as several other key changes to the surveillance system support the need to provide an updated summary of the status of the National HIV Surveillance System .
Surveillance data for human immunodeficiency virus (HIV) infection have been used for many years at the federal, state, and local levels to monitor the spread of HIV, plan prevention programs and health-care services, and allocate funding for prevention and care. [1] [2] [3] [4] [5] [6] The continued and increasing need for high-quality, usable surveillance data was underscored by the release of the 2010 National HIV/AIDS Strategy (NHAS), which calls for a coordinated national response to HIV in the United States. 7 To maximize the ability to monitor trends in HIV in the U.S. and progress toward meeting prevention goals, the Centers for Disease Control and Prevention (CDC) has developed a comprehensive National HIV Surveillance System (NHSS) that guides data collection and reporting.
In 2007, Glynn et al. reported on the status of HIV case surveillance in the U.S. as of 2006. 1 At that time, national data on HIV infection were available only for cases diagnosed through 2004 in 33 states with longterm confidential name-based HIV reporting. Implementation of reporting differed by area; however, by April 2008, all 50 states, the District of Columbia (DC), and six U.S. dependent areas (American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin Islands) had implemented confidential name-based HIV infection reporting. [8] [9] [10] The 2011 HIV Surveillance Report included, for the first time, estimated data on diagnosed HIV infections for all areas. 2 Changes have occurred in HIV surveillance that support the need to describe the current status of the NHSS.
MetHoDS

HIV case surveillance
Conducting HIV case surveillance. HIV infection is one of many nationally notifiable diseases defined by the Council of State and Territorial Epidemiologists in collaboration with CDC. State, local, and territorial governments hold the legal authority for public health surveillance. Although reporting of HIV cases to CDC is voluntary, it is essential to the nationwide aggregation and monitoring of the burden of disease.
Surveillance jurisdictions are responsible for identifying and gathering data on people diagnosed with HIV infection in accordance with state and territorial laws and for reporting the data to CDC without personal identifying information. New cases of HIV infection are typically identified passively through laboratory reports of HIV antibody, antigen, or viral detection tests. Case information is collected on standardized case report forms, which are completed by providers or through active follow-up with reporting entities (e.g., clinics and hospitals) by health department staff.
To ensure uniform reporting practices and provide standardized guidelines for HIV surveillance, CDC developed and maintains the Technical Guidance for HIV Surveillance Programs (Unpublished document, CDC, 2013). For all cases, health departments use document-based surveillance methods, which include collection, storage, and management of all case reports, laboratory test results, and other documents in their original formats, and allow programs to monitor cases longitudinally. Jurisdictions collect demographic, clinical, vital status, and risk data for use at the local level and submission to CDC. Laboratory test results used to diagnose and monitor HIV infection (e.g., CD4 T-lymphocyte [CD4] and viral load [VL] results) are also reported.
Uniform reporting also requires a standardized method for storing and managing reports of individual cases of HIV. The Enhanced HIV/AIDS Reporting System (eHARS) is a browser-based, CDC-developed application that assists health departments with reporting, data management, analysis, and transfer of data to CDC. Each surveillance program maintains a separate eHARS installation and submits de-identified data monthly to CDC through a secure data network. 11 HIV surveillance case definition. As the capacity and need to monitor the burden of HIV disease has evolved, so too has the HIV surveillance case definition. Early case definitions defined HIV and acquired immunodeficiency syndrome (AIDS) as separate entities. The 2008 revised case definition for HIV infection among adults and adolescents incorporated a staging system that categorizes AIDS as HIV infection, stage 3, and underscores that AIDS is late-stage HIV infection, rather than a separate disease. 12 The case definition will continue to be updated, as needed, to ensure the most accurate monitoring of HIV disease (e.g., to incorporate new diagnostic testing algorithms or monitor acute HIV infection [stage 0]). 13 Monitoring the spectrum of disease. HIV may be detected at various points along the spectrum of disease, and reportable events range from reporting HIV exposure among infants, to HIV infection in asymptomatic people, to late-stage disease (HIV infection, stage 3 [AIDS]), to death ( Figure 1 ). In addition to monitoring these key events, the increased demand to use HIV surveillance data for public health action (e.g., linkage to and engagement in HIV medical care) has resulted in most states expanding data collection to include all values of CD4 and VL test results. 3-6 Figure 1 . The spectrum of reportable events in HIV surveillance, definitions, and key uses of data to monitor HIV infection longitudinally in the U.S. System evaluation and data quality. Surveillance programs routinely evaluate their systems to monitor data quality and identify possible sources of underreporting and delays in reporting. Twice annually, they also review cases identified as potential duplicates to ensure a negligible proportion of duplicates in the system. At the national level, CDC conducts a duplicate review across states to ensure that each case is counted only once in the NHSS.
Spectrum of reportable events in HIV surveillance
CDC developed program standards (i.e., process and outcome measures) for evaluating completeness, timeliness, risk factor ascertainment, death ascertainment, and de-duplication. 15, 16 To ensure consistency in evaluating these program standards, CDC develops and disseminates evaluation tools to surveillance programs. Additional evaluation activities conducted by programs include reviewing surveillance methods and redirecting resources to case-finding methods that are the most effective and productive.
Data analysis and dissemination.
HIV surveillance programs are responsible for analyzing and disseminating data in the form of an annual surveillance report and an epidemiologic profile. 17 The annual surveillance report describes the epidemiology of HIV (e.g., case counts, rates, and trends) in a local area in terms of demographic and risk characteristics. The epidemiologic profile describes the burden of HIV disease in an area in terms of sociodemographic, geographic, behavioral, and clinical characteristics. These reports complement one another and are used at the state and local levels to allocate HIV prevention and care resources, plan and evaluate programs and policies, and monitor the goals of NHAS.
At the national level, HIV surveillance data are analyzed and disseminated through national surveillance reports and slide series; the National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease (STD), and Tuberculosis (TB) Prevention (NCHHSTP) Atlas; and other sources for a wide range of uses. For example, data are disseminated to the Health Resources and Services Administration to allocate funding for the Ryan White CARE Act and to the U.S. Department of Housing and Urban Development for the Housing Opportunities for Persons with AIDS Program. National surveillance data are also used to monitor the goals of NHAS, plan HIV prevention programs, and allocate funding for HIV prevention and care. 2, 3, 18 HIV incidence surveillance HIV diagnosis depends on testing practices and can occur at any point after infection. As a result, HIV diagnoses do not necessarily represent new infections. To provide reliable and scientifically valid local, state, and national estimates of the number of newly acquired infections (diagnosed and undiagnosed), selected surveillance programs conduct HIV incidence surveillance (HIS). HIS data are used to (1) describe the characteristics of newly infected populations and subgroups; (2) monitor trends in transmission; (3) assist with local, state, and national planning and evaluation activities; and (4) monitor the outcomes of HIV prevention programs and strategies.
As an integrated component of the NHSS, HIS jurisdictions incorporate into routine case surveillance the collection of additional data elements. HIS jurisdictions obtain data on history of HIV testing and antiretroviral use from patient interviews, medical record reviews, provider reports, records of partner services, and HIV laboratory test results sent to health departments. HIS jurisdictions also collect remnant diagnostic HIVpositive blood specimens for testing using an immunoassay for recency to distinguish between recent and longstanding infections on a population level. Using a stratified extrapolation approach, data on the history of testing and antiretroviral use, recency test results, and other case surveillance data are extrapolated to the general population to generate estimates of HIV incidence. [19] [20] [21] [22] Other activities Select jurisdictions opt to conduct additional activities under HIV case surveillance, including molecular HIV surveillance, perinatal HIV exposure reporting, and geocoding of HIV surveillance data (Figure 2) . 23, 24 Security and confidentiality standards One goal of NCHHSTP is to strengthen collaborative work across disease areas and integrate services that are provided by state and local programs for the prevention of HIV, viral hepatitis, other STDs, and TB. A past barrier to achieving this goal was the lack of standardized data security and confidentiality procedures. In 2011, NCHHSTP released the "Data 
Methods
Jurisdictions collect HIV nucleotide sequence data from laboratories that conduct HIV genotypic drug resistance testing and obtain ART use history data for newly diagnosed people .
Practical application Phylogenetic analysis and other analytical methods can be applied to assess HIV drug resistance, evaluate HIV genetic diversity, and describe HIV transmission patterns . Results of such analyses enhance the understanding of HIV infection and its spread through various populations and can substantially contribute to efforts to prevent HIV transmission . Molecular HIV surveillance data can also serve as markers of access to care and assist HIV treatment, prevention, and program planning and evaluation .
Perinatal HIV exposure surveillance
Participating jurisdictions
Areas with laws and regulations in place that allow the collection of data on HIV-exposed infants .
Purpose
To identify and monitor perinatally exposed infants and their mothers .
Methods
Jurisdictions collect data on infants born to HIV-infected women identified through (1) regular contact with delivery hospitals and pediatric and obstetric clinics, (2) the identification of pregnancy among women known to HIV case surveillance, and (3) routine linkage between the HIV case surveillance database and birth registries . Surveillance data are ascertained through review of medical charts of the mother-infant pairs and longitudinal follow-up of the exposed infant from birth to 18 months of age . If perinatal transmission of HIV has occurred, the infant is reported to the state, local, or territorial HIV surveillance program following the standard operating procedures for case surveillance .
Practical application Data can be used to monitor perinatal HIV exposure, outcomes among pregnant HIVinfected women, longitudinal pediatric HIV outcomes, and long-term effects of ART on the infant during pregnancy and after birth; and to inform HIV testing, prevention, and treatment programs .
Geocoding HIV surveillance data
Participating jurisdictions
Select jurisdictions
Purpose To enhance the understanding of the geographic distribution of HIV within an area to inform planning for prevention activities and HIV care and treatment services .
Methods
Jurisdictions use a geographic information system to geocode (i .e ., assign latitude and longitude coordinates) residence at diagnosis of HIV infection for all people in the jurisdiction diagnosed with HIV in a given time period . Program collaboration and service integration HIV surveillance programs have been encouraged to support NCHHSTP's strategic priority of program collaboration and service integration (PCSI). PCSI promotes improved integration of HIV, viral hepatitis, STD, and TB prevention and treatment services at the client level through enhanced collaboration at the health department jurisdictional level, as well as organizational program level. PCSI allows opportunities to (1) increase efficiency, reduce redundancy, and eliminate missed opportunities; (2) increase flexibility and better adapt to overlapping diseases and risk behaviors; and (3) improve operations through the use of shared data. 26 outcoMeS HIV surveillance data provide accurate and timely information to (1) monitor and characterize the trends and burden of HIV infection; (2) ensure a reliable measure of the number of people in need of HIV prevention and care services; (3) plan, prioritize, and allocate resources for HIV prevention, intervention, and care programs; and (4) monitor and evaluate the impact of HIV prevention, intervention, and care programs on the key outcome indicators of the NHAS. The NHSS will continue to evolve and expand as the need for high-quality HIV surveillance data increases.
Practical application
leSSonS learneD
The major lessons learned regarding the development and maintenance of a highly functional and useful NHSS are as follows:
1. Surveillance programs must establish and maintain relationships with providers and laboratories to ensure complete and timely reporting. Although all jurisdictions have reporting regulations, not all providers and laboratories consistently adhere to them.
2. Standardization and complete entry of laboratory data is needed to provide an accurate picture of HIV in the U.S. Efforts have been made to improve and standardize the entry of laboratory data into eHARS. 3. HIV surveillance data can be used for public health action by monitoring access to care in jurisdictions with complete laboratory reporting. NCHHSTP has developed a standard set of security and confidentiality guidelines encouraging increased data sharing among surveillance programs, HIV prevention, and other disease programs to help facilitate this action.
